Mirum Pharmaceuticals (MIRM) Shares Issued (2019 - 2026)

Mirum Pharmaceuticals has reported Shares Issued for 8 years, with the latest figure at $10.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 59.32% year-over-year to $10.1 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (down 26.81% YoY), and the FY2023 full-year result was $14.5 million, down 83.18% from the prior year.
• Shares Issued for Q1 2026 stood at $10.1 million, up from -$31.1 million in the prior quarter.
• The five-year high for Shares Issued was $187.9 million in Q3 2023, with the low at -$187.9 million in Q4 2023.
• Average Shares Issued over 5 years is $5.1 million, with a median of $6.8 million recorded in 2024.
• Year-over-year, Shares Issued jumped 2842.43% in 2022 and sank 67001.07% in 2023.
• Tracing MIRM's Shares Issued over 5 years: stood at -$280000.0 in 2022, then slumped by 67001.07% to -$187.9 million in 2023, then surged by 93.42% to -$12.4 million in 2024, then plunged by 151.99% to -$31.1 million in 2025, then soared by 132.53% to $10.1 million in 2026.
• The last three Shares Issued figures came in at $10.1 million (Q1 2026), -$31.1 million (Q4 2025), and $16.1 million (Q3 2025), per Business Quant data.

Peer Comparison